These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 20935647)

  • 1. IL-37 is a fundamental inhibitor of innate immunity.
    Nold MF; Nold-Petry CA; Zepp JA; Palmer BE; Bufler P; Dinarello CA
    Nat Immunol; 2010 Nov; 11(11):1014-22. PubMed ID: 20935647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of innate inflammation and immunity by interleukin-37.
    Dinarello CA; Nold-Petry C; Nold M; Fujita M; Li S; Kim S; Bufler P
    Eur J Immunol; 2016 May; 46(5):1067-81. PubMed ID: 27060871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 37 limits monosodium urate crystal-induced innate immune responses in human and murine models of gout.
    Liu L; Xue Y; Zhu Y; Xuan D; Yang X; Liang M; Wang J; Zhu X; Zhang J; Zou H
    Arthritis Res Ther; 2016 Nov; 18(1):268. PubMed ID: 27863506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-37 isoform D downregulates pro-inflammatory cytokines expression in a Smad3-dependent manner.
    Zhao M; Li Y; Guo C; Wang L; Chu H; Zhu F; Li Y; Wang X; Wang Q; Zhao W; Shi Y; Chen W; Zhang L
    Cell Death Dis; 2018 May; 9(6):582. PubMed ID: 29789615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells.
    Conti P; Carinci F; Lessiani G; Spinas E; Kritas SK; Ronconi G; Caraffa A; Theoharides TC
    Immunol Res; 2017 Oct; 65(5):982-986. PubMed ID: 28748328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role for nuclear interleukin-37 in the suppression of innate immunity.
    Li S; Amo-Aparicio J; Neff CP; Tengesdal IW; Azam T; Palmer BE; López-Vales R; Bufler P; Dinarello CA
    Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4456-4461. PubMed ID: 30792349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-36γ and IL-36 receptor signaling mediate impaired host immunity and lung injury in cytotoxic Pseudomonas aeruginosa pulmonary infection: Role of prostaglandin E2.
    Aoyagi T; Newstead MW; Zeng X; Nanjo Y; Peters-Golden M; Kaku M; Standiford TJ
    PLoS Pathog; 2017 Nov; 13(11):e1006737. PubMed ID: 29166668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging role of interleukin-37 in cardiovascular diseases.
    Zhuang X; Wu B; Li J; Shi H; Jin B; Luo X
    Immun Inflamm Dis; 2017 Sep; 5(3):373-379. PubMed ID: 28548248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cell in innate immunity mediated by proinflammatory and antiinflammatory IL-1 family members.
    Robuffo I; Toniato E; Tettamanti L; Mastrangelo F; Ronconi G; Frydas I; Caraffa Al; Kritas SK; Conti P
    J Biol Regul Homeost Agents; 2017; 31(4):837-842. PubMed ID: 29254286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-37 inhibits IL-18-induced tubular epithelial cell expression of pro-inflammatory cytokines and renal ischemia-reperfusion injury.
    Yang Y; Zhang ZX; Lian D; Haig A; Bhattacharjee RN; Jevnikar AM
    Kidney Int; 2015 Feb; 87(2):396-408. PubMed ID: 25207880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of inflammation and acquired immunity by IL-37.
    Cavalli G; Dinarello CA
    Immunol Rev; 2018 Jan; 281(1):179-190. PubMed ID: 29247987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation.
    Gehrke N; Hövelmeyer N; Waisman A; Straub BK; Weinmann-Menke J; Wörns MA; Galle PR; Schattenberg JM
    J Hepatol; 2018 May; 68(5):986-995. PubMed ID: 29366909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-37.
    Dinarello CA; Bufler P
    Semin Immunol; 2013 Dec; 25(6):466-8. PubMed ID: 24275599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-37 improves T-cell-mediated immunity and chimeric antigen receptor T-cell therapy in aged backgrounds.
    Hamilton JAG; Lee MY; Hunter R; Ank RS; Story JY; Talekar G; Sisroe T; Ballak DB; Fedanov A; Porter CC; Eisenmesser EZ; Dinarello CA; Raikar SS; DeGregori J; Henry CJ
    Aging Cell; 2021 Feb; 20(2):e13309. PubMed ID: 33480151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspase-1-processed IL-1 family cytokines play a vital role in driving innate IL-17.
    Dungan LS; Mills KH
    Cytokine; 2011 Oct; 56(1):126-32. PubMed ID: 21824786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-37 a New IL-1 Family Member Emerges as a Key Suppressor of Asthma Mediated by Mast Cells.
    Conti P; Ronconi G; Caraffa A; Lessiani G; Duraisamy K
    Immunol Invest; 2017 Apr; 46(3):239-250. PubMed ID: 27982737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human β-defensin-3 increases the expression of interleukin-37 through CCR6 in human keratinocytes.
    Smithrithee R; Niyonsaba F; Kiatsurayanon C; Ushio H; Ikeda S; Okumura K; Ogawa H
    J Dermatol Sci; 2015 Jan; 77(1):46-53. PubMed ID: 25541254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the inflammasome-related cytokines Il-1 and Il-18 during infection with murine coronavirus.
    Zalinger ZB; Elliott R; Weiss SR
    J Neurovirol; 2017 Dec; 23(6):845-854. PubMed ID: 28895072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insight into interleukin-37: The potential therapeutic target in allergic diseases.
    Huang Z; Xie L; Li H; Liu X; Bellanti JA; Zheng SG; Su W
    Cytokine Growth Factor Rev; 2019 Oct; 49():32-41. PubMed ID: 31672283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.